Ascendis Pharma (ASND)
(Delayed Data from NSDQ)
$136.93 USD
-6.25 (-4.37%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $136.88 -0.05 (-0.04%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
04/25/2024
Time: -- |
3/2024 | $-1.57 | 13.61% |
Earnings Summary
For their last quarter, Ascendis Pharma (ASND) reported earnings of -$1.66 per share, beating the Zacks Consensus Estimate of $-2.15 per share. This reflects a positive earnings surprise of 22.79%. Look out for ASND's next earnings release expected on April 25, 2024. For the next earning release, we expect the company to report earnings of -$1.57 per share, reflecting a year-over-year increase of 25.94%.
Earnings History
Price & Consensus
Zacks News for ASND
Are Medical Stocks Lagging AdaptHealth (AHCO) This Year?
ASND: What are Zacks experts saying now?
Zacks Private Portfolio Services